Design, synthesis, and bioevaluation of 1 <i>h</i> -pyrrolo[3,2- <i>c</i> ]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities-Reference-Cited by-同舟云学术

Design, synthesis, and bioevaluation of 1 h -pyrrolo[3,2- c ]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities

Published:2024-01-14 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Wang Chao¹²,Zhang Yujing³,Yang Shanbo¹²,Shi Lingyu¹²,Rong Rong⁴,Zhang Tingting¹²,Wu Yudong¹²,Xing Dongming¹²⁵

Affiliation:

1. Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China

2. Qingdao Cancer Institute, Qingdao University, Qingdao, China

3. The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao University, Qingdao, China

4. Yantai Key laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, China

5. School of Life Sciences, Tsinghua University, Beijing, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong

Natural Science Foundation of Qingdao

Medical and Health Science and Technology Development Plan Project of Shandong

China Postdoctoral Science Foundation

Qingdao Postdoctoral Application Project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2024.2302320

Reference37 articles.

1. Microtubule-targeting agents: strategies to hijack the cytoskeleton;Steinmetz MO;Trends Cell Biol,2018

2. Discovery, synthesis, and evaluation of highly selective vascular endothelial growth factor receptor 3 (VEGFR3) inhibitor for the potential treatment of metastatic triple-negative breast cancer;Li Y;J Med Chem,2021

3. Heterocyclic-fused pyrimidines as novel tubulin polymerization inhibitors targeting the colchicine binding site: structural basis and antitumor efficacy;Banerjee S;J Med Chem,2018

4. Microtubule-binding agents: a dynamic field of cancer therapeutics;Dumontet C;Nat Rev Drug Discov,2010

5. An overview of microtubule targeting agents for cancer therapy;Karahalil B;Arh Hig Rada Toksikol,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, molecular insights, and structure-activity relationship;Journal of Molecular Structure;2025-02

2. Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors;Future Medicinal Chemistry;2024-03-22